Limited Competitive Continuation for Ahrq Centers for Education and Research on Therapeutics Program

The summary for the Limited Competitive Continuation for Ahrq Centers for Education and Research on Therapeutics Program grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competitive Continuation for Ahrq Centers for Education and Research on Therapeutics Program: The Agency for Healthcare Research and Quality (AHRQ) announces the availability of limited competitive continuation funds for awards to existing Centers for Education and Research on Therapeutics (CERTs) whose initial funding commenced in 2000. The purpose of these awards is to allow these grantees to build on their current work in progress and to expand the work to: (a) develop and implement educational strategies focused on translating the most promising findings of current work into everyday practice; (b) address existing gaps within the overall CERTs program including pharmacoeconomics, cost effectiveness analyses, and education; (c) enhance the work of the CERTs, consistent with the AHRQ patient safety agenda; and (d) develop additional projects within each center's overarching center theme that was previously determined to be complementary to AHRQ research priorities and responsive to the needs and goals of programs of the Department of Health and Human Services (DHHS), as discussed below. This program began with the release of RFA: HS-99-004 on January 27, 1999, and the subsequent award of grants pursuant to the Food and Drug Administration Modernization Act of 1997 which authorized the AHCPR (now AHRQ), in coordination with FDA, to carry out a demonstration program to conduct research and provide objective information on drugs, biologics, and devices. AHRQ continues to manage this program under the Agency's reauthorizing legislation, P.L. 106-129, enacted in December 1999. The program's legislative mandate is to "conduct state-of-the-art research to increase awareness of: (1) new uses of drugs, biological products, and devices; (2) ways to improve the effective use of drugs, biological products, and devices; and (3) risks of new uses and risks of combinations of drugs and biological products." Further, the legislation directs "CERTs to provide objective clinical information to the following individuals and entities: (1) health care practitioners and other providers of health care goods or services; (2) pharmacists, pharmacy benefit managers and purchasers; (3) health maintenance organizations and other managed health care organizations; (4) health care insurers and governmental agencies; and (5) patients and consumers." Additionally the centers are to "investigate various ways to improve the quality of health care while reducing the cost of health care through an increase in the appropriate use of drugs, biological products, and devices and the prevention of adverse effects of drugs, biological products, and devices and the consequences of such effects, such as unnecessary hospitalizations." Finally, the CERTs will "conduct research on the comparative effectiveness, cost-effectiveness, and safety of drugs, biological products, and devices." CERTs is an ongoing multi-year program that supports research demonstration centers. The CERTs program is mandated by Congress. Because the existing CERTs recipients possess the infrastructure, leadership, organization, and multidisciplinary research objectives to enable them to build on the existing work to address existing gaps and to develop additional projects, and because continuity in the research is necessary, this will be a limited competition. In addition, ongoing evaluation of the CERTs demonstration activities require that a longer period of funding be in place for the current awardees in order to determine the appropriate structure for the permanent Agency program. Detailed information on the program can be obtained at
Federal Grant Title: Limited Competitive Continuation for Ahrq Centers for Education and Research on Therapeutics Program
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HS-03-002
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.226
CFDA Descriptions: Research on Healthcare Costs, Quality and Outcomes
Current Application Deadline: No deadline provided
Original Application Deadline: Jul 15, 2003
Posted Date: May 14, 2003
Creation Date: Aug 14, 2003
Archive Date: Aug 14, 2003
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster NIH OER Webmaster
Similar Government Grants
Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18)
AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01)
Using Data Analytics to Support Primary Care and Community Interventions to Improve Chroni...
Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at...
Screening and Management of Unhealthy Alcohol Use in Primary Care: Dissemination and Imple...
Small Grant Program for Conference Support (R13)
Ahrq Health Services Research
Ahrq Grant Program for Large Conference Support
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020